As of December 16, 2015, 12 long-term follow-up interviews have been completed for participants in our Phase 2 study of MDMA-assisted psychotherapy for 23 subjects with chronic, treatment-resistant PTSD. This study has enrolled a total of 29 subjects, with six dropouts, and all experimental treatments have been completed. Primary outcome data is collected after each participant’s second experimental MDMA-assisted psychotherapy session, with long-term follow-up interviews taking place 12 months following their third and final experimental session. Long-term follow-up data will provide additional information to guide the design of our upcoming Phase 3 trials. “The combination of the psychedelic and the therapist was such a healing thing for me because I could go places I couldn’t go before,” writes Elizabeth, a study participant. “I can’t tell you how valuable that was—how valuable that is.” The final results will begin to be prepared for publication in early 2016, with publication expected in late 2016.